Balance Sheet
Cash Flow Statement
AmortizationAmortizationAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Free Cash Flow (2016 - 2025)

Avricore Health has reported Free Cash Flow over the past 12 years, most recently at -$209622.2 for Q4 2025.

  • Quarterly Free Cash Flow fell 183.17% to -$209622.2 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$513405.7 through Dec 2025, down 159.19% year-over-year, with the annual reading at -$502032.8 for FY2025, 157.97% down from the prior year.
  • Free Cash Flow was -$209622.2 for Q4 2025 at Avricore Health, roughly flat from -$210328.9 in the prior quarter.
  • Over five years, Free Cash Flow peaked at $481194.6 in Q3 2022 and troughed at -$1.5 million in Q4 2022.
  • The 5-year median for Free Cash Flow is -$61324.3 (2022), against an average of -$39422.5.
  • Year-over-year, Free Cash Flow soared 326.55% in 2022 and then crashed 1036.14% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$379559.0 in 2021, then crashed by 284.65% to -$1.5 million in 2022, then surged by 129.75% to $434352.2 in 2023, then plummeted by 41.97% to $252043.3 in 2024, then tumbled by 183.17% to -$209622.2 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Free Cash Flow are -$209622.2 (Q4 2025), -$210328.9 (Q3 2025), and -$292951.8 (Q2 2025).